[1] Sies H. Oxidative stress: a concept in redox biology and medicine[J]. Redox Biol, 2015, 4: 180-183. [2] Seebacher NA, Krchniakova M, Stacy AE, et al. Tumour microenvironment stress promotes the development of drug resistance[J]. Antioxidants (Basel), 2021, 10:1801-1833. [3] Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 168: 960-976. [4] 曹楚楚,黄炉仁,傅芬. PI3K/Akt/mTOR信号通路及其相关基因突变与子宫内膜癌靶向性药物治疗的研究进展[J]. 基础医学与临床, 2017, 37: 118-122. [5] Zhang H, Bajraszewski N, Wu E, et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR[J]. J Clin Invest, 2007, 117: 730-738. [6] Wu J, Yeung SJ, Liu S, et al. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS[J]. Signal Transduct Target Ther, 2021, 6: 188-201. [7] Liu R, Li X, Ma H, et al. Spermidine endows macrophages anti-inflammatory properties by inducing mitochondrial superoxide-dependent AMPK activation, Hif-1alpha upregulation and autophagy[J]. Free Radic Biol Med, 2020, 161: 339-350. [8] Duvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1[J]. Mol Cell, 2010, 39: 171-183. [9] 盖晓晨,汤步富,刘芳铭,等. mTOR负调控miR-27a并通过靶向降低GP73抑制人肝癌细胞侵袭[J]. 基础医学与临床, 2017, 37: 1015-1020. [10] Csibi A, Fendt SM, Li C, et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4[J]. Cell,2013, 153: 840-854. [11] Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health[J]. J Nutr, 2004, 134: 489-492. [12] Brautigam L, Zhang J, Dreij K, et al. MGST1, a GSH transferase/peroxidase essential for development and hematopoietic stem cell differentiation[J]. Redox Biol, 2018, 17: 171-179. [13] Rodrik-Outmezguine VS, Okaniwa M, Yao Z, et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor[J]. Nature, 2016, 534: 272-276. |